1. Home
  2. RSVR vs CTMX Comparison

RSVR vs CTMX Comparison

Compare RSVR & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reservoir Media Inc.

RSVR

Reservoir Media Inc.

N/A

Current Price

$9.27

Market Cap

642.8M

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$2.79

Market Cap

716.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RSVR
CTMX
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
642.8M
716.9M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
RSVR
CTMX
Price
$9.27
$2.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$11.50
$12.10
AVG Volume (30 Days)
49.7K
3.5M
Earning Date
05-27-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
8.33
N/A
EPS
0.13
N/A
Revenue
$175,664,491.00
$76,201,000.00
Revenue This Year
$10.95
N/A
Revenue Next Year
$4.16
$7.61
P/E Ratio
$71.92
$22.58
Revenue Growth
10.69
N/A
52 Week Low
$7.07
$1.90
52 Week High
$13.39
$8.21

Technical Indicators

Market Signals
Indicator
RSVR
CTMX
Relative Strength Index (RSI) 42.75 29.17
Support Level $7.31 N/A
Resistance Level $10.34 $3.93
Average True Range (ATR) 0.34 0.22
MACD -0.02 -0.07
Stochastic Oscillator 55.80 2.05

Price Performance

Historical Comparison
RSVR
CTMX

About RSVR Reservoir Media Inc.

Reservoir Media Inc is an independent music company. The company operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the U.S. Music Publishing segment engaged in the acquisition of interests in music catalogs to earn royalties and signing songwriters to agreements of future delivery of songs. The Recorded Music segment involve the acquisition of sound recording catalogs and the discovery and development of recording artists and the marketing, distribution, sale and licensing of the music catalog.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: